Sugar free transforming growth factor β1 increases the fitness of myelodysplastic neoplasm / acute myeloid leukemia cells

Sugar free transforming growth factor β1 increases the fitness of myelodysplastic neoplasm / acute myeloid leukemia cells

Not available.

Saved in:

Bibliographic Details
Main Author:	Eric Solary
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2025-06-01
Series:	Haematologica
Online Access:	https://haematologica.org/article/view/12146
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immature forms of low density granulocytes are increased in acute myeloid leukemia and myelodysplastic syndromes
by: Angela Bertolini, et al.
Published: (2025-03-01)

Myelodysplastic Syndrome/Acute Myeloid Leukemia Arising in Idiopathic Erythrocytosis
by: Stephen E. Langabeer, et al.
Published: (2018-01-01)

STAT signaling in the pathogenesis and therapy of acute myeloid leukemia and myelodysplastic syndromes
by: Zoe King, et al.
Published: (2025-03-01)

TRANSFORMATION OF MYELODYSPLASTIC SYNDROME (REFRACTORY ANEMIA WITH EXCESS BLASTS) INTO ACUTE MYELOID LEUKEMIA – A CLINICAL CASE
by: Михаил Дмитриевич Неверов, et al.
Published: (2020-09-01)

Advances in the role of the IGF signaling system in myelodysplastic syndromes and acute myeloid leukemia
by: Yifan Wang, et al.
Published: (2025-06-01)

INFECTIOUS COMPLICATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND CORRELATED MYELOID NEOPLASM TREATED WITH AZACITIDINE: AN UNICENTRIC COHORT
by: AFV Agreda, et al.
Published: (2024-10-01)

PD-1 inhibition for relapse after allogeneic transplantation in acute myeloid leukemia and myelodysplastic syndrome
by: John M. Magenau, et al.
Published: (2025-08-01)

RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia
by: Tim Kong, et al.
Published: (2025-01-01)

PROGNOSIS AND THERAPY WHEN ACUTE PROMYELOCYTIC LEUKEMIA AND OTHER “GOOD RISK” ACUTE MYELOID LEUKEMIAS OCCUR AS A THERAPY-RELATED MYELOID NEOPLASM
by: Richard A. Larson, et al.
Published: (2011-07-01)

Jumping Translocations of 1q in Myelodysplastic Syndrome and Acute Myeloid Leukemia: Report of Three Cases and Review of Literature
by: T. Couture, et al.
Published: (2018-01-01)

Phenotypic and functional changes of NK cells in patients with myelodysplastic syndrome and acute myeloid leukemia treated with hypomethylating drugs
by: D. I. Zhigarev, et al.
Published: (2021-05-01)

The Role of Hypomethylating Agents Prior to Allogeneic Hematopoietic Stem Cells Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome
by: VN Ovechkina, et al.
Published: (2017-07-01)

Myelodysplastic Neoplasms (MDS): Pathogenesis and Therapeutic Prospects
by: Xuefeng Li, et al.
Published: (2025-05-01)

Acute pro-B-cell lymphoblastic leukemia evolving from myelodysplastic neoplasm post-cytotoxic therapy: a case report
by: Jana Wobst, et al.
Published: (2025-04-01)

Identification of common hub genes and construction of immune regulatory networks in aplastic anemia, myelodysplastic syndromes, and acute myeloid leukemia
by: Mingliang Shan, et al.
Published: (2025-05-01)

The Role of BCL-2 Expression in Patients with Myelodysplastic Neoplasms
by: Bartłomiej Kuszczak, et al.
Published: (2025-05-01)

Comment on “Acute pro-B-cell lymphoblastic leukemia evolving from myelodysplastic neoplasm post cytotoxic therapy: a case report”
by: Arndt Borkhardt
Published: (2025-05-01)

Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
by: Adriano Venditti, et al.
Published: (2025-05-01)

Laboratory diagnostics stages of myelodysplastic syndrome transformation into acute erythroid leukemia (clinical case report)
by: I. E. Volgina
Published: (2022-01-01)

Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center
by: Betül Oran, et al.
Published: (2025-07-01)

Characteristics and outcomes of patients with lymphoma who developed therapy-related acute myeloid leukemia or myelodysplastic syndrome – a retrospective analysis of the Polish Adult Leukemia Group
by: Aleksandra Gołos, et al.
Published: (2024-07-01)

Myelodysplastic Neoplasms: The Impact of Clonality on Inflammatory-Degenerative Diseases of the Elderly
by: Nicolas Bonadies
Published: (2024-03-01)

Dysregulation of transposable elements and PIWI-interacting RNAs in myelodysplastic neoplasms
by: Zdenek Krejcik, et al.
Published: (2025-01-01)

Perspectives of Patients With Relapsed and Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome on Patient–Clinician Communication About Prognosis and the Future
by: Vinay Rao, et al.
Published: (2024-10-01)

Transformation of Chronic Myeloid Leukemia to Acute Undifferentiated Leukemia: Case Report and Literature Review
by: Oussama Grari, et al.
Published: (2025-04-01)

Ruxolitinib and decitabine plus a busulfan–cyclophosphamide conditioning regimen for relapse prophylaxis in patients with high-risk acute myeloid leukemia or myelodysplastic syndromes
by: Yujun Wei, et al.
Published: (2025-08-01)

The risk of myelodysplastic syndrome and acute myeloid leukemia by metformin use and type 2 diabetes status – a Danish nation-wide cohort study
by: Emelie C. Rotbain, et al.
Published: (2025-05-01)

The risk of myelodysplastic syndrome and acute myeloid leukemia by metformin use and type 2 diabetes status – a Danish nation-wide cohort study
by: Umar Aziz
Published: (2025-07-01)

A clinico-genomic prognostic model for primary myelodysplastic neoplasm in Asia
by: Harinder Gill, et al.
Published: (2025-07-01)

“Low‐risk” myelodysplastic neoplasm (MDS): Time for a name change?
by: Shoshana Burke, et al.
Published: (2025-01-01)

Venetoclax synergizes with Wnt/β-catenin inhibitor C-82 in acute myeloid leukemia by increasing the degradation of Mcl-1 protein
by: Mengya Pan, et al.
Published: (2025-05-01)

A correlation of ineffective erythropoiesis and dysregulated signaling pathways in myelodysplastic syndromes/neoplasms
by: Junying Wu, et al.
Published: (2025-05-01)

ASSESSMENT OF THE FEASIBILITY AND SAFETY OF ASSISTED CALORIC RESTRICTION (FMD) IN PATIENTS WITH MYELODYSPLASTIC NEOPLASMS
by: FJAB Ribeiro, et al.
Published: (2024-10-01)

Impaired LTB4-induced neutrophil chemotactic directionality in myelodysplastic neoplasms patients
by: Xinyan Xie, et al.
Published: (2025-12-01)

Bone marrow microenvironment in myelodysplastic neoplasms: insights into pathogenesis, biomarkers, and therapeutic targets
by: Forouzan Bahmani, et al.
Published: (2025-05-01)

What Is Acute Myeloid Leukemia?
by: Daniel Mazza Matos, et al.
Published: (2025-06-01)

Comparative clinical and economic analysis of pozaconazol (Noxafil) for invasive mycoses (IM) prevention in patients with severe neutropenia during treatment of acute myeloid leukemia or myelodysplastic syndrome
by: I. S. Krysanov, et al.
Published: (2019-04-01)

Trans-differentiation of plasma cell neoplasm to acute myeloid leukemia with monocytic features: Case report of divergent phenotype with identical genotype
by: Saja Asakrah, et al.
Published: (2025-01-01)

Flow Cytometry Analysis of Mesenchymal Stem Cells: A Predictive Biomarker for Leukemia Transformation in Myelodysplastic Syndrome
by: Mireia Atance, et al.
Published: (2025-06-01)

Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
by: Ali Alsugair, et al.
Published: (2025-01-01)